A new trading day began on Friday, with Dexcom Inc (NASDAQ: DXCM) stock price down -0.54% from the previous day of trading, before settling in for the closing price of $84.84. DXCM’s price has ranged from $62.34 to $142.00 over the past 52 weeks.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
It was noted that within the last five years, the titan of the Healthcare sector saw sales topped by 25.24%. Meanwhile, its annual earnings per share averaged 11.54%. With a float of $385.65 million, this company’s outstanding shares have now reached $390.60 million.
The extent of productivity of a business whose workforce counts for 9600 workers is very important to gauge. In terms of profitability, gross margin is 61.68%, operating margin of 15.88%, and the pretax margin is 18.81%.
Dexcom Inc (DXCM) Insider Updates
As we move forward, let’s examine how large-scale investors are investing in this stock of the Medical Devices Industry. The insider ownership of Dexcom Inc is 1.26%, while institutional ownership is 93.10%. The most recent insider transaction that took place on Dec 16 ’24, was worth 32,593. In this transaction EVP, Chief HR Officer of this company sold 424 shares at a rate of $76.87, taking the stock ownership to the 70,768 shares. Before that another transaction happened on Dec 16 ’24, when Company’s EVP, Chief Financal Officer sold 744 for $76.87, making the entire transaction worth $57,191. This insider now owns 80,030 shares in total.
Dexcom Inc (DXCM) Performance Highlights and Predictions
Wall Street market experts anticipate that the next fiscal year will bring earnings of 0.38 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 11.54% per share during the next fiscal year.
Dexcom Inc (NASDAQ: DXCM) Trading Performance Indicators
Here are Dexcom Inc’s current performance indicators. According to the last quarter’s results, the stock had a quick ratio of 2.12. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 8.34. Likewise, its price to free cash flow for the trailing twelve months is 61.60.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is 1.67, a number that is poised to hit 0.51 in the next quarter and is forecasted to reach 2.02 in one year’s time.
Technical Analysis of Dexcom Inc (DXCM)
The latest stats from [Dexcom Inc, DXCM] show that its last 5-days average volume of 5.11 million was superior to 3.95 million than last year’s volume. As of the previous 9 days, the stock’s Stochastic %D was 84.73%. Additionally, its Average True Range was 3.03.
During the past 100 days, Dexcom Inc’s (DXCM) raw stochastic average was set at 90.96%, which indicates a significant increase from 84.66% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 35.29% in the past 14 days, which was higher than the 32.78% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $77.38, while its 200-day Moving Average is $92.85. Now, the first resistance to watch is $85.84. This is followed by the second major resistance level at $87.31. The third major resistance level sits at $88.28. If the price goes on to break the first support level at $83.40, it is likely to go to the next support level at $82.43. Assuming the price breaks the second support level, the third support level stands at $80.96.
Dexcom Inc (NASDAQ: DXCM) Key Stats
With a market capitalization of 32.96 billion, the company has a total of 390,595K Shares Outstanding. Currently, annual sales are 3,622 M while annual income is 541,500 K. The company’s previous quarter sales were 994,200 K while its latest quarter income was 134,600 K.
